Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novartis AG (CH:NOVN – Research Report), CompuGroup Medical (GB:0MSD – Research Report) and GlaxoSmithKline (GB:GSK – Research Report).
CompuGroup Medical (GB:0MSD)
In a report issued on July 18, Florian Treisch from Kepler Capital maintained a Buy rating on CompuGroup Medical, with a price target of EUR56.00. The company’s shares closed yesterday at EUR46.80, close to its 52-week low of EUR46.36.
Treisch has an average return of
According to TipRanks.com, Treisch is ranked #5810 out of 8524 analysts.
CompuGroup Medical has an analyst consensus of Moderate Buy, with a price target consensus of EUR57.67.
GlaxoSmithKline (GB:GSK)
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline yesterday and set a price target of £14.00. The company’s shares closed last Friday at p1378.00.
According to TipRanks.com, Gordon is a 2-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for GlaxoSmithKline with a p1493.33 average price target, which is a 7.3% upside from current levels. In a report issued on July 14, HSBC also initiated coverage with a Sell rating on the stock with a p1190.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
